Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

ABSTRACT:

Background

The majority of breast cancer patients use complementary and/or integrative therapies during and beyond cancer treatment to manage symptoms, prevent toxicities, and improve quality of life. Practice guidelines are needed to inform clinicians and patients about safe and effective therapies.

Methods

Following the Institute of Medicine's guideline development process, a systematic review identified randomized controlled trials testing the use of integrative therapies for supportive care in patients receiving breast cancer treatment. Trials were included if the majority of participants had breast cancer and/or breast cancer patient results were reported separately, and outcomes were clinically relevant. Recommendations were organized by outcome and graded based upon a

SUBMITTER: Greenlee H 

PROVIDER: S-EPMC4411539 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature